Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Mélanomes cutanés
- | Specialty :
- Chimiothérapie
Extract
BRIM 3: A randomized, open-label, controlled, multicenter, global study on progression-free and overall survival in previously untreated patients with unresectable stage IIIC or stage IV melanoma with V600E BRAF mutation receiving RO5185426 or dacarbazine.
Scientific Abstract
en cours d'intégration;